Michael Lauzardo

Michael Lauzardo, MD, MSc

Associate Professor Of Medicine; Deputy Director Of Emerging Pathogens Institute

Department: MD-MEDICINE GLOBAL HEALTH
Business Phone: (352) 273-9378
Business Email: lauzam@medicine.ufl.edu

About Michael Lauzardo

Michael Lauzardo, MD, MSc, is an associate professor within the division of infectious diseases and global medicine. Also serving as the director of the CDC funded Southeastern National Tuberculosis Center (SNTC) at the University of Florida, he has been involved in public health, teaching and patient care within the College of Medicine since 1997. Trained as an internist and pulmonologist, throughout his career he has been involved in the clinical care of patients with tuberculosis. He has also played a key role with the Florida Department of Health, serving as the Deputy TB Controller for the Florida TB Program and is currently the director of the Florida TB Physicians Network. Previously, he was the chief of the division of infectious diseases and global medicine. His clinical practice and research centers around tuberculosis among at-risk populations and he is involved in various international health activities.

Accomplishments

Vice President/Program Chair North American Region
2008-2010 · International Union Against Tuberculosis and Lung Disease
Bryant L. Galusha Internship Award-Intern of the Year
1992 · Carolinas Medical Center

Board Certifications

  • Pulmonary Disease
    American Board of Internal Medicine

Clinical Profile

Specialties
  • Medicine
Subspecialties
  • Pulmonary Disease
Areas of Interest
  • Pulmonary tuberculosis

Research Profile

Professional Memberships: 2003-present: National TB Controllers Association  1997-present: American Thoracic Society  1997-present: International Union Against Tuberculosis and Lung Disease 1996-2000: American College of Chest Physicians 1987-1991: Christian Medical Society

Areas of Interest
  • Global Health
  • Latent tuberculosis treatment
  • Molecular epidemiology of tuberculosis
  • Tuberculosis treatment

Publications

2021
Effect of malnutrition on the pharmacokinetics of anti-TB drugs in Ghanaian children.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 25(1):36-42 [DOI] 10.5588/ijtld.20.0301. [PMID] 33384043.
2021
Effect of mixed strain infections on clinical and epidemiological features of tuberculosis in Florida.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases. 87 [DOI] 10.1016/j.meegid.2020.104659. [PMID] 33276149.
2020
Tuberculosis transmission across three states: The story of a solid organ donor born in an endemic country, 2018.
Transplant infectious disease : an official journal of the Transplantation Society. 22(6) [DOI] 10.1111/tid.13357. [PMID] 32510808.
2020
Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 100:476-482 [DOI] 10.1016/j.ijid.2020.09.025. [PMID] 32949774.
2020
Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients.
medRxiv : the preprint server for health sciences. [DOI] 10.1101/2020.08.03.20167395. [PMID] 32793914.
2020
Optimal testing choice and diagnostic strategies for latent tuberculosis infection among U.S.-born people living with HIV.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. [DOI] 10.1093/cid/ciaa1135. [PMID] 32761083.
2019
Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.
American journal of respiratory and critical care medicine. 200(10):e93-e142 [DOI] 10.1164/rccm.201909-1874ST. [PMID] 31729908.
2019
Timing of treatment interruption among latently infected tuberculosis cases treated with a nine-month course of daily isoniazid: findings from a time to event analysis.
BMC public health. 19(1) [DOI] 10.1186/s12889-019-7524-4. [PMID] 31481046.
2019
Whole genomic sequencing as a tool for diagnosis of drug and multidrug-resistance tuberculosis in an endemic region in Mexico.
PloS one. 14(6) [DOI] 10.1371/journal.pone.0213046. [PMID] 31166945.
2019
Eliminating tuberculosis: the importance of paediatric tuberculosis surveillance.
The Lancet. Public health. 4(10):e485-e486 [DOI] 10.1016/S2468-2667(19)30148-3. [PMID] 31446051.
2019
Direct transmission of within-host Mycobacterium tuberculosis diversity to secondary cases can lead to variable between-host heterogeneity without de novo mutation: A genomic investigation.
EBioMedicine. 47:293-300 [DOI] 10.1016/j.ebiom.2019.08.010. [PMID] 31420303.
2019
Impact and Effectiveness of State-Level Tuberculosis Interventions in California, Florida, New York, and Texas: A Model-Based Analysis.
American journal of epidemiology. 188(9):1733-1741 [DOI] 10.1093/aje/kwz147. [PMID] 31251797.
2019
Tuberculosis in the United States: Medical Consultation Services Provided by 5 Tuberculosis Regional Training and Medical Consultation Centers, 2013-2017.
Open forum infectious diseases. 6(6) [DOI] 10.1093/ofid/ofz167. [PMID] 31205971.
2018
Genetic diversity of drug and multidrug-resistant Mycobacterium tuberculosis circulating in Veracruz, Mexico.
PloS one. 13(3) [DOI] 10.1371/journal.pone.0193626. [PMID] 29543819.
2018
Genomic Investigation of a Mycobacterium tuberculosis Outbreak Involving Prison and Community Cases in Florida, United States.
The American journal of tropical medicine and hygiene. 99(4):867-874 [DOI] 10.4269/ajtmh.17-0700. [PMID] 29987998.
2018
Health care workers’ recommendations for strengthening tuberculosis infection control in the Dominican Republic.
Revista panamericana de salud publica = Pan American journal of public health. 42 [DOI] 10.26633/RPSP.2018.169. [PMID] 31093197.
2018
Management and diagnosis of tuberculosis in solid organ transplant candidates and recipients: Expert survey and updated review.
Journal of clinical tuberculosis and other mycobacterial diseases. 11:37-46 [DOI] 10.1016/j.jctube.2018.04.001. [PMID] 31720390.
2018
Moving Closer to Tuberculosis Elimination through Institutional Scientific Collaboration: Opportunities for Cuba and the USA.
MEDICC review. 20(2):59-63 [PMID] 29773780.
View on: PubMed
2018
Mycobacterium bovis BCG spinal osteomyelitis in a patient with bladder cancer without a history of BCG instillation.
BMJ case reports. 2018 [DOI] 10.1136/bcr-2018-224462. [PMID] 30065051.
2018
Tuberculosis Mortality in the United States: Epidemiology and Prevention Opportunities.
Annals of the American Thoracic Society. 15(6):683-692 [DOI] 10.1513/AnnalsATS.201705-405OC. [PMID] 29490150.
2017
Association between Mycobacterium tuberculosis lineage and site of disease in Florida, 2009-2015.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases. 55:366-371 [DOI] 10.1016/j.meegid.2017.10.004. [PMID] 28993293.
2017
Perceived Barriers to Adherence to Tuberculosis Infection Control Measures among Health Care Workers in the Dominican Republic.
MEDICC review. 19(1):16-22 [PMID] 28225541.
View on: PubMed
2017
The Role of Powerlessness Among Health Care Workers in Tuberculosis Infection Control.
Qualitative health research. 27(14):2116-2127 [DOI] 10.1177/1049732317731317. [PMID] 28962542.
2016
Spatiotemporal Clustering of Mycobacterium tuberculosis Complex Genotypes in Florida: Genetic Diversity Segregated by Country of Birth.
PloS one. 11(4) [DOI] 10.1371/journal.pone.0153575. [PMID] 27093156.
2016
Tuberculosis therapy for 2016 and beyond.
Expert opinion on pharmacotherapy. 17(14):1859-72 [DOI] 10.1080/14656566.2016.1215428. [PMID] 27457206.
2015
Description of the population structure and genetic diversity of tuberculosis in Estado de México, a low prevalence setting from Mexico.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica. 123(2):116-22 [DOI] 10.1111/apm.12312. [PMID] 25257651.
2015
Hepatotoxicity from antituberculous therapy in the elderly: a systematic review.
Tuberculosis (Edinburgh, Scotland). 95(2):112-22 [DOI] 10.1016/j.tube.2014.10.006. [PMID] 25595441.
2015
Is the Beijing strain of Mycobacterium tuberculosis associated with cavitary lung disease?
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases. 33:1-5 [DOI] 10.1016/j.meegid.2015.04.012. [PMID] 25891279.
2015
Mutations conferring resistance to first- and second-line drugs in multidrug-resistant Mycobacterium tuberculosis clinical isolates in southeast Mexico.
International journal of antimicrobial agents. 45(6):671-3 [DOI] 10.1016/j.ijantimicag.2015.02.006. [PMID] 25819011.
2015
Mycobacterium tuberculosis complex transmission is not associated with recent immigration (≤5 years) in Florida.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases. 36:547-551 [DOI] 10.1016/j.meegid.2015.08.038. [PMID] 26325684.
2015
Optimizing the dose of rifapentine to treat tuberculosis. It’s elementary.
American journal of respiratory and critical care medicine. 191(3):251-2 [DOI] 10.1164/rccm.201412-2257ED. [PMID] 25635488.
2015
Transmissibility of tuberculosis among school contacts: an outbreak investigation in a boarding middle school, China.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases. 32:148-55 [DOI] 10.1016/j.meegid.2015.03.001. [PMID] 25757905.
2014
Advances in diagnosis and treatment of latent tuberculosis infection.
Journal of the American Board of Family Medicine : JABFM. 27(5):704-12 [DOI] 10.3122/jabfm.2014.05.140062. [PMID] 25201941.
2012
Antituberculosis therapy for 2012 and beyond.
Expert opinion on pharmacotherapy. 13(4):511-26 [DOI] 10.1517/14656566.2012.657176. [PMID] 22332895.
2012
Anticipated tuberculosis stigma among health professionals and Haitian patients in South Florida.
Journal of health care for the poor and underserved. 23(2):636-50 [DOI] 10.1353/hpu.2012.0046. [PMID] 22643613.
2011
Web-accessible database of hsp65 sequences from Mycobacterium reference strains.
Journal of clinical microbiology. 49(6):2296-303 [DOI] 10.1128/JCM.02602-10. [PMID] 21450960.
2011
Decreased Early Mortality and Increased Survival With Less Intensive Therapy for Acute Lymphoblastic Leukemia (All) in the Dominican Republic (Dr)
Pediatric Blood & Cancer. 57
2010
Stigma and Therapy Completion for Latent Tuberculosis among Haitian-origin Patients.
Florida public health review. 7:32-38 [PMID] 22866274.
View on: PubMed
2010
Structural forces and the production of TB-related stigma among Haitians in two contexts.
Social science & medicine (1982). 71(8):1409-17 [DOI] 10.1016/j.socscimed.2010.07.017. [PMID] 20724052.
2009
Will new TB tests be effective in HIV-infected individuals?
HIV clinician. 21(2):13-4 [PMID] 19517623.
View on: PubMed
2006
Consider rifampin BUT be cautious.
Chest. 130(6):1638-40 [PMID] 17166975.
View on: PubMed
2004
Cultural feasibility assessment of tuberculosis prevention among persons of Haitian origin in South Florida.
Journal of immigrant health. 6(2):63-9 [PMID] 15014223.
View on: PubMed
2000
Phthisiology at the dawn of the new century.
Chest. 117(5):1455-73 [PMID] 10807837.
View on: PubMed

Grants

Aug 2020 ACTIVE
TB Physicians Consultation Network
Role: Principal Investigator
Funding: FL DEPT OF HLTH
Jan 2018 ACTIVE
SNTC 2018 TB COE Cooperative Agreement Submission.
Role: Principal Investigator
Funding: CTRS FOR DISEASE CONTROL AND PREVENTION
Nov 2017 – Jul 2019
Florida Integrated Food Safety Center of Excellence
Role: Principal Investigator
Funding: FL DEPT OF HLTH via CTRS FOR DISEASE CONTROL AND PREVENTION
Nov 2016 – Apr 2017
Florida Integrated Food Safety Center of Excellence
Role: Principal Investigator
Funding: FL DEPT OF HLTH via CTRS FOR DISEASE CONTROL AND PREVENTION
Apr 2016 – Jun 2016
Florida Integrated Food Safety Center of Excellence
Role: Principal Investigator
Funding: FL DEPT OF HLTH
Mar 2016 – Jul 2018
BacT/ALERT MP Improvement
Role: Principal Investigator
Funding: BIOMERIEUX
Nov 2015 – Apr 2016
Florida Integrated Food Safety Center of Excellence
Role: Project Manager
Funding: FL DEPT OF HLTH via CTRS FOR DISEASE CONTROL AND PREVENTION
Jul 2014 – Jun 2020
TB Physicians Consultation Network
Role: Principal Investigator
Funding: FL DEPT OF HLTH via CTRS FOR DISEASE CONTROL AND PREVENTION
Jan 2013 – Dec 2017
Tuberculosis Regional Training and Medical Consultation Centers
Role: Principal Investigator
Funding: CTRS FOR DISEASE CONTROL AND PREVENTION
Sep 2011 ACTIVE
TBESC: Prospective Comparison of the Tuberculin Skin Test (TST) vs. Interferon Gamma Release Assays (IGRAs) in Diagnosing Latent Tuberculosis Infection (LTBI)
Role: Co-Investigator
Funding: CTRS FOR DISEASE CONTROL AND PREVENTION
Mar 2008 ACTIVE
Virginia TB Foundation
Role: Principal Investigator
Funding: TUBERCULOSIS FOUNDATION OF VIRGINIA

Education

Residency – Pulmonary Disease and Critical Care
1997 · University of Florida
Residency – Internal Medicine
1994 · Carolinas Medical Center
Medical Degree
1991 · University of Florida

Teaching Profile

Courses Taught
2018-2021
IDH2930 (Un)common read
2020
PHC6937 Special Topics in Public Health
2018
MDT7090 Elective Topics
2018
BMS6300 Fund Micro and Immuno
2015-2016
PHC7980 Research for Doctoral Dissertation
2012,2014-2016
PHC7979 Advanced Research

Contact Details

Phones:
Business:
(352) 273-9378
Emails: